Scientific Program
TOA International ROP Course Theoretical Course Program
07:30 - 08:00 REGISTRATİON
08:00 - 09:30 PART I
  Moderators:
08:00 - 08:15 Opening
08:15 - 08:25 History and incidence of ROP
08:25 - 08:40 Embryonal development of the retina and Pathogenesis of ROP
08:40 - 08:45 DISCUSSION
08:45 - 08:55 Systemic, environmental and genetic factors that predispose to the development of ROP
08:55 - 09:05 ROP Screening Procedure: Concerns and Complications, Ideal environment for ROP examination and treatment
09:05 - 09:15 Unique ocular features of ROP
09:15 - 09:25 DISCUSSION
09:30 - 10:20 PART II
  Moderators:
09:30 - 09:40 Tips to use indirect ophthalmoscopy for ROP screening
09:40 - 09:50 Wide-angle systems for ROP Screening
10:20 - 10:20 DISCUSSION
10:20 - 10:40 BREAK
10:40 - 12:00 PART III
  Moderators:
10:45 - 11:00 Basic ROP classification and definitions (before ICROP-3)
11:00 - 11:15 ICROP -3
11:15 - 11:20 DISCUSSION
11:20 - 11:30 Setting up an ROP screening program and Creating national ROP Guidelines: Steps and process
11:30 - 11:40 Screening: To Whom? When? How often?
11:40 - 11:50 Artificial intelligence and ROP
11:50 - 12:00 DISCUSSION
12:00 - 13:00 PART IV
  Moderators:
12:00 - 12:10 Prospective Randomized Controlled ROP StudiesProspective Randomized Controlled ROP Studies (Pre-Anti-VEGF)
12:10 - 12:20 Prospective Randomized Controlled ROP Studies (Post Anti-VEGF)
12:20 - 12:30 Criteria for Treatment and Selection of treatment methods
12:30 - 12:40 Treatment of ROP outside the guidelines
12:40 - 12:50 A-ROP and Oxygen associated retinopathy
12:50 - 13:00 DISCUSSION
13:00 - 14:00 LUNCH
14:00 - 15:05 PART V
  Moderators:
14:00 - 14:10 Pediatric Anesthesia in Premature Infants: Challenges, Risks, and Best Practices – Lessons Learned
14:10 - 14:25 Tips for laser treatment
14:25 - 14:35 Follow-up and Retreatment criteria after laser therapy
14:35 - 14:45 Complications and management after laser therapy
14:55 - 15:05 DISCUSSION
15:05 - 16:35 PART VI
  Moderators:
15:05 - 15:20 From RCT to real world: the use of antiVEGF in the management of ROP
15:20 - 15:35 SAFER injection protocol
15:35 - 15:50 Follow-up after Anti-VEGF treatment and retreatment criteria
15:50 - 16:05 Managing PAR
16:05 - 16:15 Systemic safety related to ROP treatment
16:15 - 16:25 Role of FFA in Acute and late ROP, Techniques for Capturing the Best Images
16:25 - 16:35 Persistent Vascular Anomalies in Retinopathy of Prematurity Children: Ultra-Widefield Fluorescein Angiography Findings until School Age
16:35 - 16:45 DISCUSSION
16:30 - 16:35 Industry presentation 1:
16:35 - 16:50 BREAK
16:50 - 17:40 PART VII
16:50 - 17:40 Moderators:
16:50 - 17:05 Surgery for stage 4 ROP: indications, timing, technique, long term results
17:05 - 17:20 Surgery in Stage 5 and cicatricial ROP
17:20 - 17:30 Surgical tips for ROP
17:30 - 17:35 DISCUSSION
17:35 -17:40 Industry presentation 2:
2.nd DAY (03.10.2025) TODEM İSTANBUL
08:00 - 10:00 PART VIII
  Moderators:
08:00 - 08:15 Differential diagnosis: (FEVR, Norrie, Incontinentia Pigmenti, PFV, Coats)
08:15 - 08:30 Non-ROP neonatal retinal diseases seen during ROP care and unusual forms of ROP
08:30 - 08:40 DISCUSSION
08:40 - 08:55 Challenges in ROP screening and treatment (Premature infants with corneal opacity /2. Infants with non-dilated pupils /3. Premature infants with congenital cataracts/4. Cases with active adenoviral conjunctivitis)
08:55 - 09:10 Role of OCT in ROP and OCT biomarkers to predict ROP response to anti-VEGF
09:10 - 09:20 Experimental treatments for ROP
09:20 - 09:30 DISCUSSION
09:30 - 09:45 Clinical Features and Visual Outcomes of Patients Developing Retinal Detachment, Vitreous Hemorrhage and Retinal Break in Adult Retinopathy of Prematurity: An International Multicenter Study
09:45 - 10:00 ROP related RRD in Adolescent/Adults: Causes, Treatment, Precautions
10:00 - 10:10 DISCUSSION
10:10 - 10:30 BREAK
10:30 - 12:15 PART IX
  Moderators:
10:30 - 10:45 Strabismus in ROP survivors
10:45 - 11:00 Challenges in refractive examination in ROP and Management of amblyopia
11:00 - 11:15 Premature baby with Cataract: Management
11:15 - 11:30 Aphakia and its management in ROP patients
11:30 - 11:45 ROP and secondary Glaucoma: causes, precautions and management
11:45 - 12:00 DISCUSSION
11:40 - 11:55 Evaluation of vision in visually-impaired infants and children
11:55 - 12:05 Visual habilitation in premature infants
11:55 - 12:05 Ophthalmological impairment at 5 y old in preterm infants
12:05 - 12:15 DISCUSSION
12:15 - 13:15 LUNCH
13:15 - 15:00 PART X
  Moderators:
13:15 - 13:25 How to set up an ROP training program
13.25 - 13:45 AAO Virtual Reality Center- Virtual ROP examination, retinal laser and intra-vitreal injection training simulator
13:45 - 14:45 Panel: Case Discussions and Medicolegal Issues (Interactive Panel with sample cases)
14:45 - 14:55 BREAK
14:55 - 15:35 THEORETICAL EXAM
19:30 GALA DINNER & CERTIFICATE / DOCUMENT CEREMONY
3.rd DAY (0410.2025) TODEM İSTANBUL
08:00-17:00
SKILL TRANSFER DRY LABS

The trainees will simultaneously receive training for 120 minutes in four rooms in four small groups. After each course, there will be a 10-minute break and the trainees will move to the next room.

1. COURSE 08:00 - 10:00
BREAK 10:00 - 10:10
2. COURSE 10:10 - 12:10
LUNCH 12:10 - 13:00
3. COURSE 13:00 - 15:00
BREAK 15:00 - 15:10
4. COURSE 15:10 - 17:10
SKILL TRANSFER COURSES IN 4-DIVIDED SMALL GROUPS (WHOLE DAY)
1- STL: Neonatal Resuscitation
2- STL: Indirect ophthalmoscopic examination with Eyesi Indirect Ophthalmoscopy Simulator (Optik principles, Lenses, examination of the posterior pole and peripheral retina)
3- STL A: Laser application to phantom eyes

 

STL B: Intravitreal injection to phantom eyes

 

STL C: Basic Retinoscopy
4- STL: Clinical case discussions with slides

“The Scientific program may be subject to change.”